CMG Pharmaceutical Co., Ltd.

₩3,850As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:058820Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (18.07%)
Div yield —
ROE 2.31%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.50
PE TTM 12.26
TSR TTM (78.67%)
Mkt cap ₩57.03B
ROIC (1.40%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩3,680
(4.41%)
(42.70%)
Buy 12|7|12|4|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
47.94
52.96
52.50
52.27
7.64%
10.34%
9.16%
6.22%
Revenue₩B
2.588
2.666
2.711
2.809
(0.72%)
3.88%
4.55%
7.40%
Peers (US$42.05M)
Cap (US$)
PE
49.92M
13.31x
46.63M
2.890x
43.25M
5.361x
Capital
TTM
5Y
10Y
Leveragex
1.717
0.042
0.040
EBIT/Intx
2.097
0.220
0.218
Own earn%
(51.32)
38.44
35.89
Sh yield%
34.12
25.65
25.01
Owners
Insiders/Inst%
4.31
83.95
Short interest%
5.26
SBC / revenue%
1.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
19–26
$1 testx
—
Incr. ROIC%
3